-
VX-765 and the Translational Logic of Pyroptosis
2026-09-18
Caspase-1 sits at the intersection of inflammatory cytokine maturation and pyroptotic cell death. This thought-leadership analysis uses recent photodynamic therapy research to show how VX-765 and its active metabolite VRT-043198 can help translational researchers separate pathway causality from downstream association across cancer, inflammatory, and infectious disease models.
-
Dual-Action Inhibitors Reveal p38α Dephosphorylation
2026-09-18
The reference study shows that some p38α kinase inhibitors do more than block catalysis: they also expose the activation-loop phospho-threonine to WIP1, accelerating dephosphorylation. Its biochemical and X-ray structural results suggest that stabilizing a phosphatase-compatible kinase conformation may improve the specificity and durability of p38 MAPK inhibition.
-
Zolmitriptan Research Workflows
2026-09-17
Build a mechanistic Zolmitriptan workflow that connects 5-HT1B/1D/1F receptor signaling with vascular and neuronal readouts. The guide also shows how lysosomal assays can strengthen experimental controls without overstating evidence for an antiviral role.
-
CGI1746, σ1R, and Ferroptosis at MAMs
2026-09-17
The reference study identifies CGI1746 as a ferroptosis inhibitor that acts through the sigma-1 receptor (σ1R) at mitochondria-associated membranes (MAMs). Its experiments connect MAM-dependent calcium transfer, mitochondrial reactive oxygen species, and lipid trafficking to ferroptosis execution, offering a mechanistic framework for studying ferroptosis in cancer and cisplatin-associated kidney injury.
-
Isochlorogenic Acid A Disrupts HBV via HO-1/ROS
2026-09-16
The reference study shows that isochlorogenic acid A (ICAA) restricts hepatitis B virus at several stages, including transcription, genome production, cccDNA-associated replication, capsid formation, and envelopment. Its mechanistic contribution is to connect these phenotypes with HO-1 upregulation, intracellular ROS modulation, and possible changes in thiol-dependent viral protein assembly.
-
SHH Signaling: From Morphogen to Translational Model
2026-09-16
A mechanistic and strategic guide to using Recombinant Mouse Sonic Hedgehog as a controlled perturbation in developmental biology. The article connects comparative genital development findings with assay design, product qualification, congenital malformation research, and translational decision-making.
-
Bromodomain Inhibitor, (+)-JQ1 Workflows
2026-09-15
Bromodomain Inhibitor, (+)-JQ1 connects BET chromatin-reader inhibition with practical adipogenesis, cancer, inflammatory, and reproductive-biology assays. This guide translates the KLF6 super-enhancer study into controlled dose-response workflows, orthogonal readouts, and troubleshooting decisions.
-
Neuromedin S (rat): Practical Protocol Guide
2026-09-15
Neuromedin S (rat), SKU B5466, supplies a defined peptide agonist for controlled neuromedin U receptor signaling and GPCR/G protein signaling workflows. This guide covers preparation, controls, QC, and interpretation boundaries; use it for scientific research only, not diagnostic, therapeutic, or medical applications, and establish assay-specific activity experimentally.
-
Rhodamine B for Drift Tracing and Cell Imaging
2026-09-14
Rhodamine B converts invisible spray movement into measurable fluorescence, enabling UAV-versus-knapsack comparisons and practical drift-risk mapping. Its high solubility and established biological use also support cell-labeling screens, microscopy, and fluorescence-based assay development when matrix-specific controls are applied.
-
Lambda Protein Phosphatase for BMAL1 Assays
2026-09-14
Use Lambda Protein Phosphatase to distinguish phosphorylation-dependent BMAL1 behavior from antibody, abundance, and condensate artifacts. This practical workflow combines paired dephosphorylation controls with circadian phase-separation assays, antibody validation, and functional follow-up.
-
UPF3A Expression Across Mouse Tissues
2026-09-13
This study challenges the prevailing view that UPF3A is largely restricted to testis by quantitatively comparing UPF3A and UPF3B protein expression across mouse tissues. Its findings support a broader role for UPF3A in tissue homeostasis and refine how researchers interpret paralog-specific regulation within nonsense-mediated mRNA decay.
-
Phebestin: Multistage Antiplasmodial Evidence
2026-09-12
The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar antiplasmodial candidate active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its activity across parasite stages, persistence after washout, proposed binding to parasite aminopeptidases, and partial efficacy in infected mice provide a useful framework for evaluating next-generation malaria research chemicals.
-
Metoprolol Workflows for Cardiovascular Research
2026-09-11
Metoprolol provides a practical way to isolate beta1-adrenergic signaling while connecting cardiovascular, inflammatory, and tumor-biology assays. This guide combines concentration-response experiments, tissue-distribution logic, transporter controls, and troubleshooting strategies informed by a recent integrated pharmacokinetic study.
-
ssBIR and DNA Damage Amplification in Mouse Oocytes
2026-09-11
The reference study identifies short-scale break-induced replication (ssBIR) in fully grown mouse oocytes and shows that DNA double-strand breaks can be amplified through Rad51-dependent repair and DNA synthesis. Its combination of EdU imaging, DNA-damage markers, and replication inhibitors provides a useful framework for distinguishing localized repair synthesis from broader genome-damage responses.
-
Prostaglandin E2 in Inflammation Assays
2026-09-10
Build more interpretable inflammation experiments with Prostaglandin E2 by combining receptor-aware dosing, solvent controls, and time-resolved readouts. The workflow also shows how PGE2 can complement hydrogel-based intervertebral disc degeneration models without confusing assay extension with evidence of therapeutic efficacy.